The current treatment recommendations for persons with chronic HCV infection, genotype 1, is pegylated interferon plus ribavirin for 48 weeks. However, an early viral response, defined as a minimum of a 2-log decrease in viral load during the first 12 weeks of treatment, is predictive of a sustained viral response. Therefore, continuation of therapy in patients who fail to achieve this minimum response at 12 weeks is generally considered unnecessary.1
- Discontinue treatment.
1. Chronic hepatitis C: current disease management. Bethesda (MD): National Digestive Diseases Information Clearinghouse; 2002. NIH Publication No. 02-4230. Available at http://www.niddk.nih.gov/health/digest/pubs/chrnhepc/chrnhepc.htm. Accessed 2 Dec 2002.
Click here to return to the questions
Seminars in Medical Practice
Hospital Physician Board Review Manuals
Copyright © 2009, Turner White Communications
Updated 1/04/08 kkj